Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New vaccine method could save millions
cow
In the past, BTV outbreaks have been able to spread for up to two years before a new vaccine could be developed.
Scientists find a way to fast-track the development of new Bluetongue vaccines

Glasgow scientists have found a faster way to produce vaccines for new strains of Bluetongue. The breakthrough could save the European economy millions by preventing the virus' devastating spread.

Bluetongue virus (BTV) has caused the deaths of thousands of livestock animals globally. It is spread by a certain type of midge and affects cattle, sheep and some other wild ruminants.

The outbreak of BTV-8 in 2008 is thought to have cost the Dutch economy around €80 million.

Traditionally, methods of prevention include culling of animals or the use of inactivated vaccines, which contain viruses killed by chemical methods.

While these vaccines have been a key tool in outbreaks across Europe over the past decade, they only prevent one strain of BTV. There are at least 26 different serotypes and when a new strain of the virus emerges, a new vaccine is usually required. In the past, BTV outbreaks have been able to spread for up to two years before a new vaccine could be developed.

Researchers from the University of Glasgow and Merial Animal Health have come up with a novel solution to the problem, which cuts design and production time by six months.

In the Journal of Virology, scientists explain how they have applied a "synthetic biology" approach, whereby synthetic viral particles are created in the laboratory. As the vaccine is not dependent on live, infectious viruses, it may be safer than current vaccines.

Lead researcher Massimo Palmarini, who is director of Glasgow's Centre for Virus Research, said: "Our findings demonstrate a clear advantage for the use of synthetic vaccine technology when compared with more traditional options.

"Overall, this vaccine platform can significantly reduce the time taken from the identification of newly emerging BTV strains to the development and production of new effective vaccines.

"They can be brought to the market more quickly but with the same level of quality and reliability as traditional vaccines. This is a big step towards a more sustainable, effective and rapid method of disease prevention."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.